{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:46:25Z","timestamp":1795110385415,"version":"4.10.3"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Capital's Funds for Health Improvement and Research","award":["No.2020-2-2231"],"award-info":[{"award-number":["No.2020-2-2231"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"abstract":"<jats:p>This study aims to identify novel immunological, metabolic, and inflammatory determinants of ankylosing spondylitis (AS) using Mendelian randomization (MR), offering new insights into its pathogenesis and potential therapeutic interventions. Employing a bidirectional, secondary validation two-sample MR, this study investigated causal associations among 1400 serum metabolites, 731 immune cell traits, and 91 circulating inflammatory proteins with AS. Instrumental variables were identified using PLINK for minimal linkage disequilibrium, applying strict significance thresholds. Various MR methodologies, including inverse variance weighted, weighted median, and MR Egger, were applied to validate causal links. Sensitivity analyses, incorporating heterogeneity and pleiotropy tests, were performed to evaluate the robustness of the results. The false discovery rate correction was applied to adjust for multiple comparisons, while the MR Steiger directionality test and bidirectional MR analysis validated the causation direction. Secondary validation with data from diverse sources was undertaken to confirm the reliability of the findings. After false discovery rate correction, associations were identified between AS etiology and 9 immune cell traits, 2 serum metabolites, and 2 inflammatory proteins. Notably, the presence of CX3CR1 on monocytes and the absolute count of CD62L- CD86+ myeloid dendritic cells (DCs) were associated with an increased risk of AS. In contrast, expression of HLA DR on DCs, including myeloid and plasmacytoid DCs, and on CD14- CD16- monocytes, along with CD64 expression across various monocyte subsets (monocytes, CD14+ CD16+, and CD14+ CD16-), correlated with a decreased risk of AS development. Serum metabolites, specifically levels of hexadecanedioate and Bilirubin (E, Z or Z, E), were also linked to a reduced risk of AS. Regarding inflammatory factors, interleukin-6 levels were inversely associated with AS morbidity, whereas TNF-beta levels were positively correlated with higher AS morbidity. Neither bidirectional MR nor MR Steiger tests provided evidence supporting reverse causation. This study sheds light on the complex interactions between immune cells traits, metabolites, and inflammatory proteins in AS, offering new insights into its pathophysiology. The findings underscore the importance of the immune\u2013metabolic\u2013inflammation network in AS, suggesting novel biomarkers for diagnosis and targets for therapy.<\/jats:p>","DOI":"10.1097\/md.0000000000042177","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:01:30Z","timestamp":1746529290000},"page":"e42177","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling new therapeutic targets in ankylosing spondylitis: Multi-omics Mendelian randomization on immune cells, metabolites, and inflammation proteins"],"prefix":"10.1097","volume":"104","author":[{"given":"Kai","family":"Du","sequence":"first","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Heng","family":"Zuo","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pain Medicine, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7460-1349","authenticated-orcid":false,"given":"Shu-Ming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pain Medicine, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250904","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis.","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology (Oxford, England)"},{"key":"R2-20250904","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/rheumatology\/ken195","article-title":"Predicting outcome in ankylosing spondylitis.","volume":"47","author":"Pradeep","year":"2008","journal-title":"Rheumatology (Oxford, England)"},{"key":"R3-20250904","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/1756-185X.14547","article-title":"Ankylosing spondylitis: History, epidemiology, and HLA-B27.","volume":"26","author":"Khan","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"R4-20250904","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.22831","article-title":"Global prevalence of spondyloarthritis: A systematic review and meta-regression analysis.","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R5-20250904","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11926-021-01043-5","article-title":"Worldwide differences in clinical phenotype of axial spondyloarthritis.","volume":"23","author":"Bittar","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"R6-20250904","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11926-017-0640-1","article-title":"An update on the genetic polymorphism of HLA-B*27 With 213 Alleles Encompassing 160 Subtypes (and Still Counting).","volume":"19","author":"Khan","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"R7-20250904","doi-asserted-by":"crossref","first-page":"750542","DOI":"10.3389\/fimmu.2021.750542","article-title":"Regulatory T Cells: Regulation of identity and function.","volume":"12","author":"Grover","year":"2021","journal-title":"Front Immunol"},{"key":"R8-20250904","doi-asserted-by":"crossref","first-page":"616949","DOI":"10.3389\/fimmu.2020.616949","article-title":"The complex role of regulatory T cells in immunity and aging.","volume":"11","author":"Rocamora-Reverte","year":"2021","journal-title":"Front Immunol"},{"key":"R9-20250904","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/annrheumdis-2023-eular.4557","article-title":"Ab1049 the status of Breg cells in patients with ankylosing spondylitis.","volume":"82","author":"Luo","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R10-20250904","doi-asserted-by":"crossref","first-page":"e13235","DOI":"10.1111\/sji.13235","article-title":"Decreased levels of T follicular helper (CD4+CXCR5+) cells and CD27+CD38+ and CD27+CD38\u2212 B cells in ankylosing spondylitis patients correlate with markers of inflammation.","volume":"97","author":"Lejon","year":"2023","journal-title":"Scand J Immunol"},{"key":"R11-20250904","doi-asserted-by":"crossref","first-page":"565275","DOI":"10.3389\/fimmu.2020.565275","article-title":"Innate lymphocytes in inflammatory arthritis.","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"key":"R12-20250904","doi-asserted-by":"crossref","first-page":"894580","DOI":"10.3389\/fimmu.2022.894580","article-title":"Contemplating dichotomous nature of gamma delta T cells for immunotherapy.","volume":"13","author":"Bhat","year":"2022","journal-title":"Front Immunol"},{"key":"R14-20250904","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/postmj\/qgad073","article-title":"Impact of immune regulation and differentiation dysfunction of mesenchymal stem cells on the disease process in ankylosing spondylitis and prospective analysis of stem cell transplantation therapy.","volume":"99","author":"Feng","year":"2023","journal-title":"Postgrad Med J"},{"key":"R15-20250904","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1302\/2046-3758.122.BJR-2022-0195.R1","article-title":"Cytokines and regulatory T cells in ankylosing spondylitis.","volume":"12","author":"Liao","year":"2023","journal-title":"Bone Joint Res"},{"key":"R16-20250904","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/annrheumdis-2016-eular.3395","article-title":"AB0706 lipid profile and active systemic inflammation may differently affect the pathomechanism of cardiovascular disorders in ankylosing spondylitis (AS) and in psoriatic arthritis (PSA).","volume":"75","author":"Gluszko","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R17-20250904","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.3390\/jcm10153354","article-title":"Intestinal microbial metabolites in ankylosing spondylitis.","volume":"10","author":"Scalise","year":"2021","journal-title":"J Clin Med"},{"key":"R18-20250904","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fimmu.2020.00557","article-title":"Tryptophan metabolic pathways are altered in obesity and are associated with systemic inflammation.","volume":"11","author":"Cussotto","year":"2020","journal-title":"Front Immunol"},{"key":"R19-20250904","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R20-20250904","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"R21-20250904","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R22-20250904","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/ng.3368","article-title":"Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers.","volume":"47","author":"Sidore","year":"2015","journal-title":"Nat Genet"},{"key":"R23-20250904","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/s41588-020-00718-6","article-title":"Author correction: complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R24-20250904","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.joca.2021.08.003","article-title":"The causal role of gut microbiota in development of osteoarthritis.","volume":"29","author":"Yu","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"key":"R25-20250904","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R26-20250904","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2105-9-303","article-title":"A unified approach to false discovery rate estimation.","volume":"9","author":"Strimmer","year":"2008","journal-title":"BMC Bioinf"},{"key":"R27-20250904","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/art.40582","article-title":"Proinflammatory CX3CR1+CD59+ tumor necrosis factor-like molecule 1A+Interleukin-23+ monocytes are expanded in patients with ankylosing spondylitis and modulate innate lymphoid cell 3 immune functions.","volume":"70","author":"Ciccia","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R28-20250904","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3389\/fimmu.2020.01520","article-title":"GM-CSF primes proinflammatory monocyte responses in ankylosing spondylitis.","volume":"11","author":"Shi","year":"2020","journal-title":"Front Immunol"},{"key":"R29-20250904","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/apm.12757","article-title":"M2 polarization of monocytes in ankylosing spondylitis and relationship with inflammation and structural damage.","volume":"125","author":"Zhao","year":"2017","journal-title":"APMIS"},{"key":"R30-20250904","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molimm.2012.12.001","article-title":"G-protein signaling modulator-3, a gene linked to autoimmune diseases, regulates monocyte function and its deficiency protects from inflammatory arthritis.","volume":"54","author":"Gigu\u00e8re","year":"2013","journal-title":"Mol Immunol"},{"key":"R31-20250904","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1007\/s10067-022-06308-7","article-title":"Role of macrophage-associated chemokines in the assessment of initial axial spondyloarthritis.","volume":"41","author":"Li","year":"2022","journal-title":"Clin Rheumatol"},{"key":"R32-20250904","doi-asserted-by":"crossref","first-page":"3220235","DOI":"10.1155\/2023\/3220235","article-title":"A predictive disease risk model for ankylosing spondylitis: Based on integrated bioinformatic analysis and identification of potential biomarkers most related to immunity.","volume":"2023","author":"Gao","year":"2023","journal-title":"Mediators Inflamm"},{"key":"R33-20250904","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12967-023-04449-0","article-title":"CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation through NF-\u03baB signaling pathway in ankylosing spondylitis in vitro.","volume":"21","author":"Feng","year":"2023","journal-title":"J Transl Med"},{"key":"R34-20250904","doi-asserted-by":"crossref","first-page":"e22560","DOI":"10.1371\/journal.pone.0022560","article-title":"The shedding of CD62L (L-Selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes.","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"key":"R35-20250904","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10067-018-4388-4","article-title":"Dendritic cells in the pathogenesis of ankylosing spondylitis and axial spondyloarthritis.","volume":"38","author":"Slobodin","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R36-20250904","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/kev245","article-title":"Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammation.","volume":"55","author":"Wright","year":"2016","journal-title":"Rheumatology (Oxford, England)"},{"key":"R37-20250904","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/ard.46.7.497","article-title":"HLA class II antigens (DR, DQ loci) and peripheral arthritis in ankylosing spondylitis.","volume":"46","author":"Sanmart\u00ed","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"R38-20250904","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/ard.61.8.714","article-title":"Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients.","volume":"61","author":"Vargas-Alarcon","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R39-20250904","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/1529-0131(199803)41:3<460::AID-ART12>3.0.CO;2-X","article-title":"The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis.","volume":"41","author":"Brown","year":"1998","journal-title":"Arthritis Rheumatism"},{"key":"R40-20250904","first-page":"2703","article-title":"Overexpression of CD64 on CD14++CD16\u2212 and CD14++CD16+ monocytes of rheumatoid arthritis patients correlates with disease activity.","volume":"16","author":"Luo","year":"2018","journal-title":"Exp Ther Med"},{"key":"R41-20250904","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation.","volume":"8","author":"Gabay","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R42-20250904","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/ard.2007.071605","article-title":"Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.","volume":"67","author":"Visvanathan","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R43-20250904","doi-asserted-by":"crossref","first-page":"18000","DOI":"10.1038\/s41598-019-54549-5","article-title":"Effect of tumor necrosis factor inhibition on spinal inflammation and spinal ankylosis in SKG mice.","volume":"9","author":"Lim","year":"2019","journal-title":"Sci Rep"},{"key":"R44-20250904","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2019-216741","article-title":"Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence.","volume":"79","author":"Koo","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R45-20250904","first-page":"330","article-title":"The clinic importance of bilirubin parameters in ankylosing spondylitis: Case control study.","volume":"2","author":"Koca","year":"2018","journal-title":"J Surg Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:01:13Z","timestamp":1756987273000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":44,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042177","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}